SenesTech Inc.
(SNES)
undefined
undefined%
At close: undefined
4.11
2.75%
After-hours Dec 13, 2024, 07:59 PM EST
Company Description
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control.
It offers ContraPest, a liquid bait that limits reproduction of male and female rats.
The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
SenesTech Inc.
| Country | United States |
| IPO Date | Dec 8, 2016 |
| Industry | Chemicals - Specialty |
| Sector | Basic Materials |
| Employees | 25 |
| CEO | Joel L. Fruendt |
Contact Details
Address: 23460 North 19th Avenue Phoenix, Arizona United States | |
| Website | https://www.senestech.com |
Stock Details
| Ticker Symbol | SNES |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001680378 |
| CUSIP Number | 81720R208 |
| ISIN Number | US81720R5054 |
| Employer ID | 20-2079805 |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Joel L. Fruendt | Chief Executive Officer, President & Director |
| Thomas C. Chesterman M.B.A. | Executive Vice President, Chief Financial Officer, Treasurer & Secretary |
| Robert Blum | Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Nov 12, 2024 | 8-K | Current Report |
| Oct 04, 2024 | 424B3 | Filing |
| Sep 23, 2024 | S-3 | Filing |
| Aug 30, 2024 | D | Filing |
| Aug 28, 2024 | 4 | Filing |
| Aug 28, 2024 | 4 | Filing |